Key result
Low and high heparin concentrations facilitate thrombin inactivation via distinct mechanisms including heparin co-factor.
Why the study?
The antithrombin activity of plasma, serum, and plasma fractions under different experimental conditions and heparin concentrations was not fully characterized.
This basic science study characterizes the mechanisms of thrombin inactivation in plasma and serum, identifying the role of a heparin co-factor at high heparin concentrations.
Answers are grounded in this paper and cite their sources.
Does not support clinical heparin dosing changes; leaves open distinct thrombin inactivation mechanisms for further study.
Summary The antithrombin activity of plasma, serum and plasma fractions has been studied under different experimental conditions. Two different methods have been used for the assay of antithrombin activity. Under the experimental conditions described the following antithrombin activities have been found to be of importance in the inactivation of thrombin: 1. Progressive inactivation in the absence of heparin can take place in plasma and to a less extent in defibrinated plasma and serum. 2. Inactivation of thrombin in presence of fibrinogen and heparin in low concentration (about 0.03 I.U./ml). This effect was abolished at high heparin levels. 3. Inactivation of thrombin by plasma, defibrinated plasma and serum at high concentrations of heparin (about 2—15 I.U./ml). This activity is tentatively named the heparin co-factor.
No takes yet. Share an insight, caveat, or question.
Blombäck et al. (1963) studied this question. Heparin vs. Absence of heparin was evaluated on Inactivation of thrombin. Heparin at low concentrations and high concentrations facilitates thrombin inactivation in plasma and serum through distinct mechanisms, including heparin co-factor.
Synapse has enriched 10 related papers. Consider them for comparative context: